Embryonal Carcinoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary Metastasectomy
 Conditions : Neoplasm Metastasis; Sarcoma; Neoplasms, Germ Cell and Embryonal; Melanoma Interventions : Drug: decitabine (DAC); Drug: Tetrahydrouridine (THU); Drug: Celecoxib Sponsor : National Cancer Institute (NCI) Recruiting - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 19, 2016 Category: Research Source Type: clinical trials

Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary Metastasectomy
Conditions: Neoplasm Metastasis; Sarcoma; Neoplasms, Germ Cell and Embryonal; MelanomaInterventions: Drug: decitabine (DAC); Drug: Tetrahydrouridine (THU); Drug: CelecoxibSponsor: National Cancer Institute (NCI)Recruiting - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 19, 2016 Category: Research Source Type: clinical trials

Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary Metastasectomy
Conditions: Neoplasm Metastasis; Sarcoma; Neoplasms, Germ Cell and Embryonal; Melanoma Interventions: Drug: decitabine (DAC); Drug: Tetrahydrouridine (THU); Drug: Celecoxib Sponsor: National Cancer Institute (NCI) Recruiting - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 19, 2016 Category: Research Source Type: clinical trials

Embryonal Tumors of Infancy & Childhood: South Egypt Cancer Institute Experience
Conditions: Neoplasms, Embryonal; Embryonal NeoplasmsIntervention: Sponsor: Assiut UniversityNot yet recruiting - verified January 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2016 Category: Research Source Type: clinical trials